Abstract Title:

Simvastatin Reduces Steroidogenesis by Inhibiting Cyp17a1 Gene Expression in Rat Ovarian Theca-Interstitial Cells.

Abstract Source:

Biol Reprod. 2011 Sep 21. Epub 2011 Sep 21. PMID: 21918126

Abstract Author(s):

Israel Ortega, Amanda B Cress, Donna H Wong, Jesus A Villanueva, Anna Sokalska, Benjamin C Moeller, Scott D Stanley, Antoni J Duleba


Polycystic ovary syndrome (PCOS) is characterized by ovarian enlargement, theca-interstitial hyperplasia and increased androgen production by theca cells. Previously, our group has demonstrated that statins, competitive inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase), a rate limiting step of the mevalonate pathway, reduce proliferation of theca-interstitial cells in vitro and decrease serum androgen levels in women with PCOS. The present study evaluated the effect of simvastatin on rat ovarian theca-interstitial cell steroidogenesis. Since actions of statins may be due to reduced cholesterol availability and/or isoprenylation of proteins, this study also investigated whether steroidogenesis was affected by cell- and mitochondrion- permeable 22-hydroxycholesterol, isoprenylation substrates: farnesyl-pyrophosphate (FPP) and geranylgeranyl-pyrophosphate (GGPP), as well as selective inhibitors of farnesyltransferase (FTI) and geranylgeranyltransferase (GGTI). Theca-interstitial cells were cultured for 12, 24, and 48 h with or without simvastatin, GGPP, FPP, FTI, GGTI and/or 22-hydroxycholesterol. Simvastatin decreased androgen levels in a time- and concentration-dependent fashion. This inhibitory effect correlated with a decrease in Cyp17a1 mRNA levels, the gene encoding the key enzyme regulating androgen biosynthesis. After 48 hours, GGPP alone and FPP alone had no effect on Cyp17a1 mRNA expression; however, the inhibitory action of simvastatin was partly abrogated by both GGPP and FPP. The present findings indicate that statin-induced reduction of androgen levels is likely due, at least in part, to the inhibition of isoprenylation resulting in decreased expression of CYP17A1.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.